Explore Jobs
Find Specific Jobs
Explore Careers
Explore Professions
Best Companies
Explore Companies
Pacira BioSciences history
Pacira BioSciences company history timeline
Kristen Williams worked with the company as a legal consultant before joining as Corporate Counsel in December 2011.
In 2011 he was named Vice President, Worldwide Marketing, a position in which he played a key role in the acquisition and integration of Synthes Spine.
In 2012 he was named Worldwide President, DePuy Synthes Spine, and led the spine business through the first two years of integration.
Anthony Molloy started as Associate General Counsel in December 2013.
McLoughlin joined Pacira in 2014 as part of the sales leadership team, overseeing several components of the business while fulfilling multiple roles including Chief Commercial Officer, Senior Vice President and Executive Director, Alliance Management.
Ron Ellis joined Pacira in 2016 and currently serves as Chief Strategy Officer.
Roy Winston joined Pacira in 2017 and serves as Chief Medical Officer.
Since December 2018, Charles has served as Chief Technical Officer at Pacira, overseeing the company’s research and development efforts as well as manufacturing, quality, and supply chain functions.
He previously served as Senior Vice President of Commercial Operations, a role he held at the company since June 2019.
Max Reinhardt joined Pacira in June 2019 and serves as President, Rest of World.
Doctor Jonathan Slonin joined Pacira in 2020 and currently serves as Chief Clinical Officer.
Rate Pacira BioSciences' efforts to communicate its history to employees.
Pacira BioSciences jobs
Do you work at Pacira BioSciences?
Is Pacira BioSciences' vision a big part of strategic planning?
Pacira BioSciences competitors
| Company Name | Founded Date | Revenue | Employee Size | Job Openings |
|---|---|---|---|---|
| Achillion Pharmaceuticals | 1998 | $15.0M | 56 | - |
| Chiasma | 2001 | $1.1M | 18 | - |
| Merck | 1891 | $64.2B | 74,000 | 1,169 |
| AcelRx Pharmaceuticals | 2005 | $651,000 | 54 | - |
| PerSeptive Biosystems, Inc | 1989 | - | 605 | - |
| ALZA Corporation | 1968 | $200.0M | 10,000 | - |
| Nektar Therapeutics | 1990 | $98.4M | 718 | - |
| Catalent Pharma Solutions | 2007 | $4.4B | 14,000 | 613 |
| Ivax Research | 1987 | $2.2B | 10,100 | - |
| Watson Pharma Pvt Ltd | 1984 | $5.9B | 21,600 | - |
Pacira BioSciences history FAQs
Zippia gives an in-depth look into the details of Pacira BioSciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Pacira BioSciences. The employee data is based on information from people who have self-reported their past or current employments at Pacira BioSciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Pacira BioSciences. The data presented on this page does not represent the view of Pacira BioSciences and its employees or that of Zippia.
Pacira BioSciences may also be known as or be related to Pacira BioSciences, Pacira BioSciences Inc, Pacira Pharmaceuticals, Pacira Pharmaceuticals Inc and Pacira Pharmaceuticals, Inc.